# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY AND INSTRUMENT COMBINATION TEMPLATE

A. 510(k) Number: k061431   
B. Purpose for Submission: New Device   
C. Measurand: Whole Blood Glucose   
D. Type of Test: Quantitative   
E. Applicant: US Diagnostics, Inc.

F. Proprietary and Established Names: EASYGLUCO Diabetes Monitoring System

# G. Regulatory Information:

Regulation section:   
21 CFR $\ S 8 6 2 . 1 3 4 5$ , Blood Glucose Test System   
21 CFR $\ S 8 6 2 . 1 6 6 0$ , Quality Control Material (assayed and unassayed)

2. Classification: Class II Class I, reserved

3. Product code: NBW, system, test, blood glucose, over the counter CGA, glucose oxidase, glucose JJX, single (specified) analyte controls (assayed and unassayed)

4. Panel: Clinical Chemistry (75)

# H. Intended Use:

1. Intended use(s): See Indications for use below.

2. Indication(s) for use: The EASYGLUCO™ Diabetes Monitoring System is used for the quantitative measurement of glucose level in whole blood as an aid in monitoring the effectiveness of diabetes management in the home and in clinical settings. EASYGLUCO™ System is for testing outside the body (in vitro diagnostic use only). The EASYGLUCO Diabetes Monitoring System is not for use with neonatal blood specimens. Testing sites include

the traditional fingertip testing along with alternate site testing on the arm, palm, calf and thigh.

3. Special conditions for use statement(s):

Provides plasma equivalent results.   
This product is intended for over-the-counter and point-of-care use.   
Not for neonatal use.

4. Special instrument requirements: EASYGLUCO Meter

# I. Device Description:

The "Starter Kit" which includes the glucose meter, lancing device, lancets, test strips, and control solutions are included with the EASYGLUCO Diabetes Monitoring System. Also there is "Meter Kit" which includes the glucose meter, check strip, and control solutions only.

# J. Substantial Equivalence Information:

1. Predicate device name(s): LifeScan, Inc. One Touch Ultra $\textsuperscript { \textregistered }$   
2. Predicate 510(k) number(s): k024194   
3. Comparison with predicate: The technological characteristics of the new device (EasyGluco™) in comparison to the predicate device (OneTouch $^ \mathrm { \textregistered }$ Ultra $\textsuperscript { \textregistered }$ ):

The modified EasyGluco™ device has the same technological characteristics as the current legally marketed predicate device, the ONE TOUCH $^ \mathrm { \textregistered }$ Ultra $^ \mathrm { \textregistered }$ .

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>EasyGlucoTM</td><td rowspan=1 colspan=1>ONE TOUCH® Ultra®</td></tr><tr><td rowspan=1 colspan=1>DetectionMethod</td><td rowspan=1 colspan=1>Amperometry: current isgenerated by oxidation ofreduced mediator.</td><td rowspan=1 colspan=1>Amperometry</td></tr><tr><td rowspan=1 colspan=1>Enzyme</td><td rowspan=1 colspan=1>Glucose Oxidase(Aspergillus niger)</td><td rowspan=1 colspan=1>Glucose Oxidase (Aspergillusniger)</td></tr><tr><td rowspan=1 colspan=1>Mediator</td><td rowspan=1 colspan=1>Potassium ferricyanide</td><td rowspan=1 colspan=1>Potassium ferricyanide</td></tr><tr><td rowspan=1 colspan=1>Electrode</td><td rowspan=1 colspan=1>Carbon electrode</td><td rowspan=1 colspan=1>Carbon electrode</td></tr></table>

The other ingredients of test strip, such as enzyme stabilizer, buffer and binder are different.

The EasyGluco™ Blood Glucose Monitoring System provides the same glucose monitoring capability as the predicate device, the ONE TOUCH $\textsuperscript { \textregistered }$ Ultra $^ \mathrm { \textregistered }$ . The primary differences are in the advanced memory function and battery lifetime.

<table><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">EasyGlucoTM</td><td colspan="1" rowspan="1">ONE TOUCH® Ultra®</td></tr><tr><td colspan="1" rowspan="1">Test range</td><td colspan="1" rowspan="1">20 ~ 600 mg/dL</td><td colspan="1" rowspan="1">20 ~ 600 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Hematocrit Range</td><td colspan="1" rowspan="1">30 ~55%</td><td colspan="1" rowspan="1">30 ~ 55%</td></tr><tr><td colspan="1" rowspan="1">Test Time</td><td colspan="1" rowspan="1">9 seconds</td><td colspan="1" rowspan="1">5 seconds</td></tr><tr><td colspan="1" rowspan="1">Sample Volume</td><td colspan="1" rowspan="1">1.5uL</td><td colspan="1" rowspan="1">1uL</td></tr><tr><td colspan="1" rowspan="1">Temperature &amp;Humidity range</td><td colspan="1" rowspan="1">50 ~ 104° F10 ~ 40° C10 ~ 90%</td><td colspan="1" rowspan="1">43 ~ 111°F6 ~ 44° C10 ~ 90%</td></tr><tr><td colspan="1" rowspan="1">Open use time</td><td colspan="1" rowspan="1">3 months</td><td colspan="1" rowspan="1">3 months</td></tr><tr><td colspan="1" rowspan="1">Coding</td><td colspan="1" rowspan="1">Button (C1 ~C40)</td><td colspan="1" rowspan="1">Button (C1 ~ C49)</td></tr><tr><td colspan="1" rowspan="1">Memory capability</td><td colspan="1" rowspan="1">From 7 to 90-dayaverage and 200 tests inthe memory</td><td colspan="1" rowspan="1">14-day average and last 150tests in the memory</td></tr><tr><td colspan="1" rowspan="1">Power</td><td colspan="1" rowspan="1">3V Li battery (CR2032)</td><td colspan="1" rowspan="1">3V Li battery (CR2032)</td></tr><tr><td colspan="1" rowspan="1">Battery life</td><td colspan="1" rowspan="1">Running 5,000 test</td><td colspan="1" rowspan="1">Running 1,000 test</td></tr><tr><td colspan="1" rowspan="1">Size: LxWxH(mm)</td><td colspan="1" rowspan="1">76(±1)x56(±1)x22.5(±1)</td><td colspan="1" rowspan="1">79x57x21</td></tr><tr><td colspan="1" rowspan="1">Weight</td><td colspan="1" rowspan="1">40(±1)g(with battery)</td><td colspan="1" rowspan="1">42g (with battery)</td></tr><tr><td colspan="1" rowspan="1">Warranty</td><td colspan="1" rowspan="1">3 years</td><td colspan="1" rowspan="1">3 years</td></tr><tr><td colspan="1" rowspan="1">Software</td><td colspan="1" rowspan="1">EasyGlucoTMdiabetes managementsoftware</td><td colspan="1" rowspan="1">IN TOUCH® diabetesmanagement software</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

The manufacturer of the EasyGluco Diabetes Monitoring System utilized NCCLS (EP6-P2) Evaluation of the Linearity of Quantitative Analytical Methods; Proposed Guideline – Second Edition (2001).

# L. Test Principle:

This device is an in vitro diagnostic product intended for the measurement of glucose concentration in human blood. The principle of the test relies upon a specific type of glucose in the blood sample, the dehydrogenase glucose that reacts to electrodes in the test strip. The test strip employs an electrochemical signal generating an electrical current that will stimulate a chemical reaction. This reaction is measured by the Meter and displayed as the blood glucose result.

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

The sponsor established the performance characteristics of the EASYGLUCO Diabetes Monitoring System by conducting within-run precision, and day-to-day precision studies. Results of these two sets of studies are shown below:

# a. Precision/Reproducibility:

Within day precision of the EASYGLUCO Diabetes Monitoring System was established by testing $4 \mathrm { m L }$ of blood that was treated with EDTA through a vacuum tube. Glucose was then added to the $4 \mathrm { m L }$ of blood to generate 10 different levels of glucose concentration for the test. Each of the test samples was measured 5 times. In order to obtain low samples ${ < } 2 . 8 \ \mathrm { m m o l / L }$ $( { < } 5 0 \mathrm { m g / d L } )$ , the sponsor collected

additional capillary blood samples in the appropriate anticoagulant and allowed glycolysis of the samples down to the appropriate test range. In order to obtain high samples with glucose concentration of ${ > } 2 2 . 3 \ \mathrm { m m o l / L }$ $\scriptstyle ( > 4 0 0 \mathrm { m g / d L } )$ ), the sponsor collected additional capillary blood samples in the appropriate anticoagulant and supplemented the samples with glucose. Below are the glucose concentration ranges for each level that were measured.

Summary of Test Results   

<table><tr><td>Level</td><td>Glucose Conc. range</td></tr><tr><td>NMAU</td><td>20 ~ 30 mg/dL</td></tr><tr><td></td><td>30 ~ 40 mg/dL</td></tr><tr><td></td><td>40 ~ 50 mg/dL</td></tr><tr><td></td><td>50 ~ 60 mg/dL</td></tr><tr><td></td><td>60 ~70 mg/dL</td></tr><tr><td></td><td>70 ~ 80 mg/dL</td></tr><tr><td>7</td><td>81 ~ 110 mg/dL</td></tr><tr><td>8</td><td>111 ~ 150 mg/dL</td></tr><tr><td>9</td><td>151 ~ 250 mg/dL</td></tr><tr><td>10</td><td>251 ~ 400 mg/dL</td></tr></table>

<table><tr><td rowspan="2">Control</td><td rowspan="2">No. of Assay</td><td colspan="3">Within-Run Precision</td></tr><tr><td>Mean</td><td>SD</td><td>CV</td></tr><tr><td>Samples</td><td></td><td>(mg/dL)</td><td>(mg/dL)</td><td>(%)</td></tr><tr><td>Level 1</td><td>10</td><td>25.7</td><td>1.6</td><td>6.4</td></tr><tr><td>Level 2 Level 3</td><td>10</td><td>35.4</td><td>2.2</td><td>6.3</td></tr><tr><td>Level 4</td><td>10</td><td>45.3</td><td>2.5</td><td>5.4</td></tr><tr><td></td><td>10</td><td>56.8</td><td>2.9</td><td>5.2</td></tr><tr><td>Level 5</td><td>10</td><td>65.4</td><td>2.4</td><td>3.6</td></tr><tr><td>Level 6</td><td>10</td><td>75.0</td><td>2.9</td><td>3.8</td></tr><tr><td>Level 7</td><td>50</td><td>93.7</td><td>3.2</td><td>3.4</td></tr><tr><td>Level 8</td><td>50</td><td>134.8</td><td>4.8</td><td>3.6</td></tr><tr><td>Level 9</td><td>50</td><td>214.6</td><td>4.7</td><td>2.2</td></tr><tr><td>Level 10</td><td>50</td><td>328.9</td><td>8.5</td><td>2.6</td></tr></table>

Between Day Precision was assessed by testing three different control solutions of Low, Normal and High. Each of the controls was measured twice a day, once in the morning and once in the afternoon for a month. The tables below represent the lots that were used for the study.

<table><tr><td rowspan="2">Control Samples</td><td rowspan="2">No. of Assay</td><td colspan="3">Day-to-Day Precision</td></tr><tr><td>Mean (mg/dL)</td><td>SD (mg/dL)</td><td>CV (%)</td></tr><tr><td>Low</td><td>80</td><td>50.7</td><td>1.9</td><td>3.7</td></tr><tr><td>Normal</td><td>80</td><td>111.5</td><td>2.4</td><td>2.1</td></tr><tr><td>High</td><td>80</td><td>304.3</td><td>6.6</td><td>2.2</td></tr></table>

# b. Linearity/assay reportable range:

A laboratory study tested the linearity of the EASYGLUCO Diabetes Monitoring System using EASYGLUCO Test Strips with spiked or glycolyzed venous blood samples across the claimed system test range, $\left( { 2 0 - 6 0 0 } \mathrm { m g } / \mathrm { d L } \right)$ . Nine glucose concentrations were prepared using the below dilution schemes. Each of the spiked glucose levels were tested 5 times to test for precision.

Levels of Dilution Schemes $\mathbf { S } = 9$ Samples

<table><tr><td rowspan=1 colspan=1>Level 1 (low, L)</td><td rowspan=1 colspan=1>L</td></tr><tr><td rowspan=1 colspan=1>Level 2</td><td rowspan=1 colspan=1>0.875L + 0.125H</td></tr><tr><td rowspan=1 colspan=1>Level 3</td><td rowspan=1 colspan=1>0.750L + 0.250H</td></tr><tr><td rowspan=1 colspan=1>Level 4</td><td rowspan=1 colspan=1>0.625L + 0.375H</td></tr><tr><td rowspan=1 colspan=1>Level 5</td><td rowspan=1 colspan=1>0.500L + 0.500H</td></tr><tr><td rowspan=1 colspan=1>Level 6</td><td rowspan=1 colspan=1>0.375L + 0.625H</td></tr><tr><td rowspan=1 colspan=1>Level 7</td><td rowspan=1 colspan=1>0.250L + 0.750H</td></tr><tr><td rowspan=1 colspan=1>Level 8</td><td rowspan=1 colspan=1>0.125L + 0.875H</td></tr><tr><td rowspan=1 colspan=1>Level 9 (High, H)</td><td rowspan=1 colspan=1>H</td></tr></table>

Summary of nine dilutions that were measured five (5) times.

YSI   

<table><tr><td rowspan=1 colspan=1>Dilution</td><td rowspan=1 colspan=1>Rep 1</td><td rowspan=1 colspan=1>Rep 2</td><td rowspan=1 colspan=1>Rep 3</td><td rowspan=1 colspan=1>Rep 4</td><td rowspan=1 colspan=1>Rep 5</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>1st</td><td rowspan=1 colspan=1>2nd</td><td rowspan=1 colspan=1>Mean</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>8.2</td><td rowspan=1 colspan=1>8.0</td><td rowspan=1 colspan=1>8.1</td><td rowspan=1 colspan=1>8.0</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>83</td><td rowspan=1 colspan=1>85</td><td rowspan=1 colspan=1>81</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>83</td><td rowspan=1 colspan=1>83.2</td><td rowspan=1 colspan=1>81.7</td><td rowspan=1 colspan=1>81.7</td><td rowspan=1 colspan=1>81.7</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>162</td><td rowspan=1 colspan=1>163</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>163</td><td rowspan=1 colspan=1>162</td><td rowspan=1 colspan=1>162</td><td rowspan=1 colspan=1>161</td><td rowspan=1 colspan=1>161</td><td rowspan=1 colspan=1>161</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>236</td><td rowspan=1 colspan=1>239</td><td rowspan=1 colspan=1>235</td><td rowspan=1 colspan=1>236</td><td rowspan=1 colspan=1>237</td><td rowspan=1 colspan=1>236.6</td><td rowspan=1 colspan=1>239</td><td rowspan=1 colspan=1>237</td><td rowspan=1 colspan=1>238</td></tr><tr><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>314</td><td rowspan=1 colspan=1>312</td><td rowspan=1 colspan=1>315</td><td rowspan=1 colspan=1>313</td><td rowspan=1 colspan=1>312</td><td rowspan=1 colspan=1>313.2</td><td rowspan=1 colspan=1>311</td><td rowspan=1 colspan=1>313</td><td rowspan=1 colspan=1>312</td></tr><tr><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>386</td><td rowspan=1 colspan=1>390</td><td rowspan=1 colspan=1>387</td><td rowspan=1 colspan=1>389</td><td rowspan=1 colspan=1>389</td><td rowspan=1 colspan=1>388.2</td><td rowspan=1 colspan=1>382</td><td rowspan=1 colspan=1>385</td><td rowspan=1 colspan=1>384</td></tr><tr><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>470</td><td rowspan=1 colspan=1>471</td><td rowspan=1 colspan=1>468</td><td rowspan=1 colspan=1>469</td><td rowspan=1 colspan=1>468</td><td rowspan=1 colspan=1>469.2</td><td rowspan=1 colspan=1>465</td><td rowspan=1 colspan=1>464</td><td rowspan=1 colspan=1>464</td></tr><tr><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>530</td><td rowspan=1 colspan=1>534</td><td rowspan=1 colspan=1>543</td><td rowspan=1 colspan=1>550</td><td rowspan=1 colspan=1>530</td><td rowspan=1 colspan=1>537.4</td><td rowspan=1 colspan=1>541</td><td rowspan=1 colspan=1>541</td><td rowspan=1 colspan=1>541</td></tr><tr><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>616</td><td rowspan=1 colspan=1>618</td><td rowspan=1 colspan=1>615</td><td rowspan=1 colspan=1>611</td><td rowspan=1 colspan=1>618</td><td rowspan=1 colspan=1>615.6</td><td rowspan=1 colspan=1>616</td><td rowspan=1 colspan=1>618</td><td rowspan=1 colspan=1>617</td></tr></table>

![](images/9ca51189bb022f9feca07f0b34178c2ea60d1dfa90ec96d179b29f37c7748e13.jpg)

According to the sponsor the polynomial evaluation of linearity assumes that the data set is not linear. This approach assumes that the data points fall perfectly on a line or curve in the absence of random error. The method consists of two parts. The first part examines whether a nonlinear polynomial fits the data better than a linear one. The second part assesses whether the difference between the best-fitting nonlinear and linear polynomial is less than the amount of allowable bias for the method, which should be predefined.

The nonlinear $2 ^ { \mathrm { n d } }$ fits the data better than a linear one, but the difference is lower than $1 . 3 \mathrm { m g / d L }$ from $8 . 2 \mathrm { m g / d l }$ to $6 1 5 . 6 \mathrm { m g / d L }$ . The $\mathrm { R } ^ { 2 }$ of $1 ^ { \mathrm { s t } }$ order regression is a 0.9999.

The Polynomial Evaluation of Linearity   

<table><tr><td>Dilution</td><td>Actual Mean</td><td>Predicted 1st order</td><td>Predicted 2nd order</td><td>Difference</td><td>%Difference</td></tr><tr><td>1</td><td>8.2</td><td>8.7</td><td>7.5</td><td>1.3</td><td>14.4</td></tr><tr><td>2</td><td>83.2</td><td>84.7</td><td>84.4</td><td>0.3</td><td>0.4</td></tr><tr><td>3</td><td>162</td><td>160.7</td><td>161.0</td><td>-0.4</td><td>-0.2</td></tr><tr><td>4</td><td>236.6</td><td>236.7</td><td>237.4</td><td>-0.8</td><td>-0.3</td></tr><tr><td>5</td><td>313.2</td><td>312.6</td><td>313.5</td><td>-0.9</td><td>-0.3</td></tr><tr><td>6</td><td>388.2</td><td>388.6</td><td>389.4</td><td>-0.8</td><td>-0.2</td></tr><tr><td>7</td><td>469.2</td><td>464.6</td><td>464.9</td><td>-0.4</td><td>-0.1</td></tr><tr><td>8</td><td>537.4</td><td>540.5</td><td>540.2</td><td>0.3</td><td>0.1</td></tr><tr><td>9</td><td>615.6</td><td>616.5</td><td>615.2</td><td>1.3</td><td>0.2</td></tr></table>

c. Traceability, Stability, Expected values (controls, calibrators, or methods): The company supplies glucose control solutions to validate the performance of the meter. Each level of the EasyGluco Control solutions is prepared gravimetrically and is provided in three levels. The controls are aqueous materials containing known concentration of glucose, stabilizers, buffers, preservatives and dyes. The controls targeted concentrations are $5 0 \mathrm { m g / d L }$ , $1 1 0 \mathrm { m g / d L }$ , and $3 0 0 \mathrm { m g / d L }$ .

Stability: Accelerated stability data testing suggests that the EasyGluco test strip and control solution have a shelf life of 2 years if stored between $2 { \sim } 3 0 ~ ^ { \circ } \mathrm { C }$ . Real-time stability studies are ongoing.

d. Detection limit:

See precision and linearity studies above. The operating range of the meter is $2 0 -$ $6 0 0 \mathrm { m g / d L }$ .

e. Analytical specificity:

Potential endogenous and exogenous interferents of the EasyGluco system were tested in a dose-response method following NCCLS EP7-P. A series of test samples, systematically varying in the concentration of the interferent, was prepared by making quantitative, volumetric admixtures of two pools: one at the highest concentration to be tested and the other at the lowest. The below table provides a summary of the tested interferents.

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=4>Mean of Test Results</td></tr><tr><td rowspan=1 colspan=1>Interferences</td><td rowspan=1 colspan=1>High TestLevel (mg/dL)</td><td rowspan=1 colspan=1>Low(mg/dL)</td><td rowspan=1 colspan=1>High (mg/dL)</td><td rowspan=1 colspan=1>Error %</td></tr><tr><td rowspan=1 colspan=1>Acetaminophen</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>93.0</td><td rowspan=1 colspan=1>101.6</td><td rowspan=1 colspan=1>9.2</td></tr><tr><td rowspan=1 colspan=1>Bilirubin</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>123.4</td><td rowspan=1 colspan=1>136.2</td><td rowspan=1 colspan=1>10.4</td></tr><tr><td rowspan=1 colspan=1>Gentistic acid</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>132.2</td><td rowspan=1 colspan=1>170.4</td><td rowspan=1 colspan=1>28.9</td></tr><tr><td rowspan=1 colspan=1>Uric acid</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>117.8</td><td rowspan=1 colspan=1>136.4</td><td rowspan=1 colspan=1>15.8</td></tr><tr><td rowspan=1 colspan=1>Levo-Dopa</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>120.2</td><td rowspan=1 colspan=1>125.6</td><td rowspan=1 colspan=1>4.5</td></tr><tr><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>108.2</td><td rowspan=1 colspan=1>112.6</td><td rowspan=1 colspan=1>4.1</td></tr><tr><td rowspan=1 colspan=1>Methyl-Dopa</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>106.4</td><td rowspan=1 colspan=1>111.8</td><td rowspan=1 colspan=1>5.1</td></tr><tr><td rowspan=1 colspan=1>Tolazamide</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>119.0</td><td rowspan=1 colspan=1>122.6</td><td rowspan=1 colspan=1>3.0</td></tr><tr><td rowspan=1 colspan=1>Dopamine</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>132.2</td><td rowspan=1 colspan=1>156.8</td><td rowspan=1 colspan=1>18.6</td></tr><tr><td rowspan=1 colspan=1>Ascorbate</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>122.2</td><td rowspan=1 colspan=1>125.6</td><td rowspan=1 colspan=1>2.8</td></tr><tr><td rowspan=1 colspan=1>EDTA</td><td rowspan=1 colspan=1>640</td><td rowspan=1 colspan=1>114.0</td><td rowspan=1 colspan=1>117.8</td><td rowspan=1 colspan=1>3.3</td></tr><tr><td rowspan=1 colspan=1>G;itatjopme</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>131.4</td><td rowspan=1 colspan=1>134.6</td><td rowspan=1 colspan=1>2.4</td></tr><tr><td rowspan=1 colspan=1>Heparine</td><td rowspan=1 colspan=1>1,000</td><td rowspan=1 colspan=1>122.2</td><td rowspan=1 colspan=1>124.2</td><td rowspan=1 colspan=1>1.6</td></tr><tr><td rowspan=1 colspan=1>Ibuprofen</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>102.4</td><td rowspan=1 colspan=1>106.8</td><td rowspan=1 colspan=1>4.3</td></tr><tr><td rowspan=1 colspan=1>Salicylic acid</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>121.3</td><td rowspan=1 colspan=1>124.4</td><td rowspan=1 colspan=1>2.3</td></tr><tr><td rowspan=1 colspan=1>Tetracycline</td><td rowspan=1 colspan=1>0.4</td><td rowspan=1 colspan=1>133.0</td><td rowspan=1 colspan=1>135.4</td><td rowspan=1 colspan=1>1.8</td></tr><tr><td rowspan=1 colspan=1>Tolbutamide</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>98.0</td><td rowspan=1 colspan=1>102.0</td><td rowspan=1 colspan=1>4.1</td></tr><tr><td rowspan=1 colspan=1>Urea</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>113.4</td><td rowspan=1 colspan=1>112.4</td><td rowspan=1 colspan=1>-0.9</td></tr><tr><td rowspan=1 colspan=1>Cholesterol</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>1343</td><td rowspan=1 colspan=1>142.6</td><td rowspan=1 colspan=1>6.2</td></tr><tr><td rowspan=1 colspan=1>Triglyceride</td><td rowspan=1 colspan=1>2890</td><td rowspan=1 colspan=1>120.3</td><td rowspan=1 colspan=1>137.3</td><td rowspan=1 colspan=1>14.1</td></tr><tr><td rowspan=1 colspan=1>Glactose</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>119.0</td><td rowspan=1 colspan=1>117.0</td><td rowspan=1 colspan=1>-1.7</td></tr><tr><td rowspan=1 colspan=1>Xylose</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>112.0</td><td rowspan=1 colspan=1>111.7</td><td rowspan=1 colspan=1>-0.3</td></tr><tr><td rowspan=1 colspan=1>Maltose</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>116.6</td><td rowspan=1 colspan=1>120.3</td><td rowspan=1 colspan=1>3.2</td></tr></table>

A series of five levels that included the maximum concentration of the substance that would be expected to be encountered in clinical practice were used for each substance. The interferent effect was calculated from the linear relationship between the tested concentrations of each substance.

The EasyGluco Test Strips are specific to D-glucose and do not react with other sugars which may be present. Hematocrit levels less than $30 \%$ may cause falsely high readings. Hematocrit levels greater than $5 5 \%$ may cause falsely low readings. Blood samples that contain large amounts of ascorbic acid and uric acid may cause a slightly higher result than the actual glucose level. High concentrations of Dopamine, Gentistic acid and other reducing substances may cause inaccurately high results. Lipemic samples; Cholesterol up to $5 0 0 \mathrm { m g / d L }$ or triglycerides up to $2 8 9 0 \mathrm { m g / d L }$ do not significantly affect the results.

# Temperature

Temperature studies for the EasyGluco Blood Glucose Monitoring System demonstrate that the instrument performs acceptably over the allowable operating range of the meter ( $1 0 \mathrm { { } ^ { \circ } C }$ to $4 0 \mathrm { { } ^ { \circ } C }$ or $5 0 \mathrm { { } ^ { \circ } F }$ to $1 0 4 ^ { \circ } \mathrm { F }$ ).

# High-Altitude

A simulated high-altitude study was conducted to test the effect on ${ \mathsf { p O } } _ { 2 }$ by changing the ${ \mathsf { p O } } _ { 2 }$ level in a whole blood sample from $1 5 3 \mathrm { m m H g }$ to $7 6 \mathrm { m m H } \mathrm { g }$ by Tonometry method, blowing a humidified mixed gas $( \mathrm { O } _ { 2 } , \mathrm { C O } _ { 2 }$ , and $\mathrm { N } _ { 2 } .$ ,) into the blood sample to adjust the ${ \mathsf { p O } } _ { 2 }$ level of the sample. As described in the table below that shows the barometric pressure (standard atmosphere) and equivalent tracheal ${ \mathsf { p O } } _ { 2 }$ at increasing altitudes, at 10,000 feet ${ \mathsf { p O } } _ { 2 }$ is $1 0 0 \mathrm { m m H g }$ that is $32 \%$ lower than at sea level $\left( 1 4 9 \mathrm { m m H g } \right)$ .

(Simulation $\mathsf { p O } _ { 2 }$ vs. altitude simulation below is referred to Bert, P., “La Pression   
Barometrique”, Masson et Cie, Paris: 1878   

<table><tr><td colspan="4" rowspan="1">ALTITUDE</td><td colspan="4" rowspan="1">ALTITUDE</td></tr><tr><td colspan="1" rowspan="1">m</td><td colspan="1" rowspan="1">Ft</td><td colspan="1" rowspan="1">Pressuremm Hg</td><td colspan="1" rowspan="1">pO2Tracheal airmm Hg</td><td colspan="1" rowspan="1">m</td><td colspan="1" rowspan="1">Ft</td><td colspan="1" rowspan="1">Pressuremm Hg</td><td colspan="1" rowspan="1">pO2Tracheal airmm Hg</td></tr><tr><td colspan="1" rowspan="1">0*</td><td colspan="1" rowspan="1">0*</td><td colspan="1" rowspan="1">760</td><td colspan="1" rowspan="1">149</td><td colspan="1" rowspan="1">5500</td><td colspan="1" rowspan="1">18050</td><td colspan="1" rowspan="1">379</td><td colspan="1" rowspan="1">69</td></tr><tr><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">1640</td><td colspan="1" rowspan="1">716</td><td colspan="1" rowspan="1">140</td><td colspan="1" rowspan="1">6000</td><td colspan="1" rowspan="1">19690</td><td colspan="1" rowspan="1">354</td><td colspan="1" rowspan="1">64</td></tr><tr><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">3280</td><td colspan="1" rowspan="1">674</td><td colspan="1" rowspan="1">131</td><td colspan="1" rowspan="1">6500</td><td colspan="1" rowspan="1">21330</td><td colspan="1" rowspan="1">330</td><td colspan="1" rowspan="1">59</td></tr><tr><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">4920</td><td colspan="1" rowspan="1">634</td><td colspan="1" rowspan="1">123</td><td colspan="1" rowspan="1">7000</td><td colspan="1" rowspan="1">22970</td><td colspan="1" rowspan="1">308</td><td colspan="1" rowspan="1">55</td></tr><tr><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">6560</td><td colspan="1" rowspan="1">596</td><td colspan="1" rowspan="1">115</td><td colspan="1" rowspan="1">7500</td><td colspan="1" rowspan="1">24610</td><td colspan="1" rowspan="1">287</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="1" rowspan="1">2500</td><td colspan="1" rowspan="1">8200</td><td colspan="1" rowspan="1">560</td><td colspan="1" rowspan="1">107</td><td colspan="1" rowspan="1">8000</td><td colspan="1" rowspan="1">26250</td><td colspan="1" rowspan="1">267</td><td colspan="1" rowspan="1">46</td></tr><tr><td colspan="1" rowspan="1">3000</td><td colspan="1" rowspan="1">9840</td><td colspan="1" rowspan="1">526</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">8500</td><td colspan="1" rowspan="1">27890</td><td colspan="1" rowspan="1">248</td><td colspan="1" rowspan="1">42</td></tr><tr><td colspan="1" rowspan="1">3500</td><td colspan="1" rowspan="1">11840</td><td colspan="1" rowspan="1">493</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">Everest8848</td><td colspan="1" rowspan="1">29028</td><td colspan="1" rowspan="1">232**</td><td colspan="1" rowspan="1">38.5**</td></tr><tr><td colspan="1" rowspan="1">4000</td><td colspan="1" rowspan="1">13120</td><td colspan="1" rowspan="1">462</td><td colspan="1" rowspan="1">87</td><td colspan="1" rowspan="1">9000</td><td colspan="1" rowspan="1">29530</td><td colspan="1" rowspan="1">230</td><td colspan="1" rowspan="1">38</td></tr><tr><td colspan="1" rowspan="1">4500</td><td colspan="1" rowspan="1">14650</td><td colspan="1" rowspan="1">433</td><td colspan="1" rowspan="1">81</td><td colspan="1" rowspan="1">9500</td><td colspan="1" rowspan="1">31170</td><td colspan="1" rowspan="1">214</td><td colspan="1" rowspan="1">35</td></tr><tr><td colspan="1" rowspan="1">4500</td><td colspan="1" rowspan="1">14650</td><td colspan="1" rowspan="1">433</td><td colspan="1" rowspan="1">81</td><td colspan="1" rowspan="1">9500</td><td colspan="1" rowspan="1">31170</td><td colspan="1" rowspan="1">214</td><td colspan="1" rowspan="1">35</td></tr><tr><td colspan="1" rowspan="1">5000</td><td colspan="1" rowspan="1">16400</td><td colspan="1" rowspan="1">405</td><td colspan="1" rowspan="1">75</td><td colspan="1" rowspan="1">10000</td><td colspan="1" rowspan="1">32800</td><td colspan="1" rowspan="1">198</td><td colspan="1" rowspan="1">32</td></tr><tr><td colspan="4" rowspan="1">EY</td><td colspan="1" rowspan="1">19215</td><td colspan="1" rowspan="1">63000</td><td colspan="1" rowspan="1">47</td><td colspan="1" rowspan="1">0</td></tr></table>

\* Taken at sea level   
\* Subject to fluctuations of approximately $+ / - 2 \%$ , due to weather and environmental factors

The sponsor collected venous blood from healthy donors and added the proper volume of glucose to create a low, medium, and high sample. The samples ${ \mathsf { p O } } _ { 2 }$ content was then adjusted to 76, 94, and $1 5 3 \mathrm { m m H g }$ by tonometry. The ${ \mathsf { p O } } _ { 2 }$ content of the blood samples was measured by using the Nova STAT Profile M, blood gas/electrolyte analyzer. The glucose concentration of the blood samples were measured by the YSI glucose analyzer, EasyGluco, and predicate OneTouch Ultra Blood Glucose Monitoring System. See below summary of interference by ${ \mathsf { p O } } _ { 2 }$ change.

<table><tr><td rowspan=1 colspan=3>YSI (serum)</td><td rowspan=1 colspan=3>Level 1 67mg/dL</td><td rowspan=1 colspan=3>Level 2 255 mg/dL</td><td rowspan=1 colspan=3>Level 3 451 mg/dL</td></tr><tr><td rowspan=1 colspan=3>p02 (mmHg)</td><td rowspan=1 colspan=1>153</td><td rowspan=1 colspan=1>94</td><td rowspan=1 colspan=1>76</td><td rowspan=1 colspan=1>153</td><td rowspan=1 colspan=1>94</td><td rowspan=1 colspan=1>76</td><td rowspan=1 colspan=1>153</td><td rowspan=1 colspan=1>94</td><td rowspan=1 colspan=1>76</td></tr><tr><td rowspan=2 colspan=1>EasyGluco</td><td rowspan=1 colspan=2>mg/dL</td><td rowspan=1 colspan=1>67</td><td rowspan=1 colspan=1>68</td><td rowspan=1 colspan=1>70</td><td rowspan=1 colspan=1>246</td><td rowspan=1 colspan=1>265</td><td rowspan=1 colspan=1>269</td><td rowspan=1 colspan=1>454</td><td rowspan=1 colspan=1>469</td><td rowspan=1 colspan=1>475</td></tr><tr><td rowspan=1 colspan=2>Error</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>4.5</td><td rowspan=1 colspan=1>-3.5</td><td rowspan=1 colspan=1>3.9</td><td rowspan=1 colspan=1>5.5</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>4.0</td><td rowspan=1 colspan=1>5.3</td></tr><tr><td rowspan=1 colspan=1>OneTouch</td><td rowspan=1 colspan=2>mg/dL</td><td rowspan=1 colspan=1>68</td><td rowspan=1 colspan=1>72</td><td rowspan=1 colspan=1>73</td><td rowspan=1 colspan=1>249</td><td rowspan=1 colspan=1>264</td><td rowspan=1 colspan=1>273</td><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>477</td><td rowspan=1 colspan=1>481</td></tr><tr><td rowspan=1 colspan=1>Ultra</td><td rowspan=1 colspan=2>Error</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>7.5</td><td rowspan=1 colspan=1>9.0</td><td rowspan=1 colspan=1>-2.3</td><td rowspan=1 colspan=1>3.5</td><td rowspan=1 colspan=1>7.0</td><td rowspan=1 colspan=1>-0.2</td><td rowspan=1 colspan=1>5.8</td><td rowspan=1 colspan=1>6.6</td></tr><tr><td rowspan=1 colspan=3>Simulated Altitude</td><td rowspan=1 colspan=3>153 mmHg</td><td rowspan=1 colspan=2></td><td rowspan=1 colspan=2>Sea</td><td rowspan=1 colspan=2>level</td></tr><tr><td rowspan=2 colspan=3></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=5>94 mmHg</td><td rowspan=1 colspan=3>9,840 - 11,840</td></tr><tr><td rowspan=1 colspan=5>76 mmHg</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=3>14,650  16,400</td></tr></table>

The sponsor’s acceptance criteria were the bias $\%$ $1 \mathrm { s } \pm 1 0 \%$ at the range of 80-150 $\mathrm { m m H g }$ with the standard $1 0 0 \mathrm { m m H g }$ . The error $\%$ of the OneTouch Ultra is $- 2 . 3 -$ $9 . 0 \%$ and EasyGluco is $- 3 . 5 - 5 . 5 \%$ which met the sponsor’s established acceptance criteria.

The sponsor performed an additional altitude study in an aircraft cabin at an altitude of approximately $1 { , } 5 0 0 \mathrm { m } ^ { 3 }$ . The altitude study results indicate that the EasyGluco Blood Glucose Monitoring System showed no evidence to suggest a systematic effect due to lack of atmospheric oxygen at $1 1 { , } 5 6 8 \mathrm { m }$ which is equal to 37,953 feet.

Hematocrit

Samples of blood were taken randomly from 64 diabetic patients. Adjustments were made to the hematocrit values to span a range of $30 \%$ to $5 5 \%$ . A total of eighty samples with glucose ranging from 50 to $5 8 0 \mathrm { m g / d L }$ were tested using the EasyGluco meter and the YSI. The results indicated that for 17 samples below $7 5 \mathrm { m g / d L }$ the bias ranged from $- 2 \%$ to $9 \%$ and for the 63 samples above $7 5 \mathrm { m g / d L }$ the bias ranged from $- 2 1 \%$ to $1 3 \%$ . There did not appear to be a significant change in glucose with different hematocrit values in the range tested.

f. Assay cut-off: Not applicable.

2. Comparison studies:

a. Method comparison with predicate device:

The EasyGluco Blood Glucose Monitoring System was assessed by comparing blood glucose results obtained by patients with those obtained using the Hitachi 747, a laboratory instrument. Glucose levels were measured on fresh capillary blood specimens by 100 diabetic patients (layperson) and a trained healthcare professional. Separated results were recorded by patient and healthcare professional within 2 minutes and a venous blood sample was collected within 5 minutes for testing on the Hitachi lab instrument.

$100 \%$ of the test results done by technician and $100 \%$ of the test results by consumer were within zone A of the Error Grid.

Error Grid Analysis-Hitachi 747 Vs. EasyGluco TM

![](images/82e9627a0589564e4c5ec9f62a4b0bbecdecdb14be5f2725462cf0cd54f91554.jpg)

Summary of Error Grid Analysis Results   

<table><tr><td>Total</td><td>100 Healthcare</td><td>100</td><td>100</td><td>100</td></tr><tr><td></td><td colspan="2">Professional</td><td colspan="2">Layperson</td></tr><tr><td>Zone A</td><td>Number</td><td>%</td><td>Number</td><td>%</td></tr><tr><td></td><td>100</td><td>100</td><td>100</td><td>100</td></tr><tr><td>B</td><td></td><td>0</td><td>-</td><td>0</td></tr><tr><td>C</td><td>-</td><td>0</td><td>-</td><td>0</td></tr><tr><td>D</td><td>-</td><td>0</td><td>-</td><td>0</td></tr><tr><td>E</td><td></td><td>0</td><td></td><td>0</td></tr></table>

Linear regression of the test result-Healthcare professional Vs. Layperson results

![](images/0a914577cae24b4c3ca723489e200980bfd7e9c0bb7dfb5e8edab93ebc428e6c.jpg)  
The slope is 1.0018; the $9 5 \%$ confidence interval is 0.97 to 1.02

The y-intercept is -4.15; the $9 5 \%$ confidence interval is $- 9 . 9 1$ to 1.59

The correlation coefficient is 0.9930.

All test results were within the sponsor’s established acceptance criteria.

# Physician’s Office Laboratory (POL) Study

The EasyGluco Blood Glucose Monitoring System was also evaluated at 3 independent physician’s offices. The EasyGluco test results were compared to comparative blood glucose monitoring devices currently used at the 3 POL sites. $9 8 \%$ of the comparison results carried out at the 3 different POL sites was in Zone A, and $2 \%$ were in Zone B. The glucose concentration of samples used in the POL study is $8 5 { - } 4 2 0 ~ \mathrm { m g / d L }$ (in POL 1, OneTouch Ultra), $8 5 { - } 3 9 1 ~ \mathrm { m g / d L }$ (in POL 2, YSI 2300), and $7 0 { - } 3 2 5 ~ \mathrm { m g / d L }$ (in POL 3, Glucotrend).

Test results of three independent POL sites

![](images/c561b6629d2b6108c0d123a65db590a3f1fbb9020a37622cdc4186327f76b3d2.jpg)

Error Grid Analysis Results of POL sites.   

<table><tr><td rowspan="2">Zone</td><td colspan="2">POL 1</td><td colspan="2">POL 2</td><td colspan="2">POL 3</td></tr><tr><td>Number</td><td>%</td><td>Number</td><td>%</td><td>Number %</td><td></td></tr><tr><td>A</td><td>50</td><td>100</td><td>49</td><td>98</td><td>50</td><td>100</td></tr><tr><td>B</td><td>-</td><td>-</td><td>1</td><td>2</td><td>-</td><td>-</td></tr><tr><td>C</td><td>-</td><td></td><td></td><td>-</td><td>-</td><td>-</td></tr><tr><td>D</td><td></td><td>-</td><td>-</td><td></td><td></td><td></td></tr><tr><td>E</td><td>- -</td><td></td><td>- </td><td>&#x27; </td><td>- -</td><td>I </td></tr><tr><td>Total</td><td>50</td><td>100</td><td>50</td><td>100</td><td>50</td><td>100</td></tr></table>

# Point-of-Care (POC) Study

For POC use, the EasyGluco Blood Glucose Monitoring System was evaluated at 3 different POC sites, a General Ward, Internal Medicine, and Diabetic Clinic. The EasyGluco capillary test results were compared to the Hitachi 747 venous plasma results. $100 \%$ of the comparison results carried out at the 3 different POC sites was in Zone A. The glucose concentration of samples used in the POC study is 68-410 $\mathrm { m g / d L }$ (in General Ward), $8 1 { - } 4 2 5 ~ \mathrm { m g / d L }$ (in Internal Medicine), and $7 5 { - } 3 5 2 \ \mathrm { m g / d L }$ (in Diabetic Clinic).

Test results of three POC sites at the same hospital

![](images/5046400b1575e7ca6f8b7f05da45c34a98dbd84eeb22ce586a6dba02ae0503b6.jpg)

Error Grid Analysis Results of POC sites.

<table><tr><td></td><td colspan="2">Diabetic Clinic</td><td colspan="2">Internal Medicine</td><td colspan="2">General ward</td></tr><tr><td>Zone</td><td>Number</td><td>%</td><td>Number</td><td>%</td><td>Number</td><td>%</td></tr><tr><td>A B</td><td>50</td><td>100</td><td>50</td><td>100</td><td>50</td><td>100</td></tr><tr><td>C</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>D</td><td>-</td><td>-</td><td></td><td></td><td>-</td><td>-</td></tr><tr><td></td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td></td></tr><tr><td>E</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Total</td><td>50</td><td>100</td><td>50</td><td>100</td><td>50</td><td>100</td></tr></table>

# Alternate Site Testing with the EasyGluco System:

Alternate Site Testing of the EasyGluco Blood Glucose Monitoring System was previously accessed with clearance of 510(k) submission k043512. Testing on the palm, forearm, thigh, calf, and fingertips were evaluated by using the same lancing device included with this meter. Glucose values from alternate sites were assessed in an in-house study of 160 subjects with Type 1 or Type 2 diabetes during a normally scheduled clinic visit by a trained technician. The technician first obtained fingerstick glucose readings from the subjects using the EasyGluco and OneTouch Ultra and then obtained alternate site glucose readings from the arm, palm, calf and thigh of the subjects on the EasyGluco and One Touch Ultra. The readings were taken as close in time as possible.

Within 5 minutes a venous whole blood sample was drawn from alternate sites and centrifuged for obtaining serum samples. The serum samples were tested on the Hitachi 727 chemistry analyzer.

Summary of test results with finger capillary blood and palm blood.

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Site 1</td><td rowspan=1 colspan=1>95% confidenceintervals</td><td rowspan=1 colspan=1>Site 2</td><td rowspan=1 colspan=1>95% confidenceintervals</td><td rowspan=1 colspan=1>Site 3</td><td rowspan=1 colspan=1>95% confidenceintervals</td></tr><tr><td rowspan=3 colspan=1>One Touch(Palm) vs.Hitachi 747</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>0.9777</td><td rowspan=1 colspan=1>0.9430 to 1.0124</td><td rowspan=1 colspan=1>0.9877</td><td rowspan=1 colspan=1>0.9461 to 1.0293</td><td rowspan=1 colspan=1>0.9465</td><td rowspan=1 colspan=1>0.9140 to 0.9790</td></tr><tr><td rowspan=1 colspan=1>Y-intercept</td><td rowspan=1 colspan=1>-4.7190</td><td rowspan=1 colspan=1>-11.5285 to2.0904</td><td rowspan=1 colspan=1>-0.6590</td><td rowspan=1 colspan=1>-9.3169 to7.9988</td><td rowspan=1 colspan=1>9.9481</td><td rowspan=1 colspan=1>1.9211 to15.9751</td></tr><tr><td rowspan=1 colspan=1>correlationcoefficient</td><td rowspan=1 colspan=2>0.9921</td><td rowspan=1 colspan=2>0.9894</td><td rowspan=1 colspan=2>0.9929</td></tr><tr><td rowspan=3 colspan=1>EasyGluco(Palm) vsHitachi 747</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>0.9777</td><td rowspan=1 colspan=1>0.9607 to 1.0346</td><td rowspan=1 colspan=1>0.9924</td><td rowspan=1 colspan=1>0.9506 to 1.0342</td><td rowspan=1 colspan=1>0.9683</td><td rowspan=1 colspan=1>0.9285 to 1.0079</td></tr><tr><td rowspan=1 colspan=1>Y-intercept</td><td rowspan=1 colspan=1>-4.5480</td><td rowspan=1 colspan=1>-11.7994 to2.7033</td><td rowspan=1 colspan=1>0.2117</td><td rowspan=1 colspan=1>-8.4862 to8.9096</td><td rowspan=1 colspan=1>1.0728</td><td rowspan=1 colspan=1>-7.5158 to9.6613</td></tr><tr><td rowspan=1 colspan=1>correlationcoefficient</td><td rowspan=1 colspan=2>0.9914</td><td rowspan=1 colspan=2>0.9894</td><td rowspan=1 colspan=2>0.9900</td></tr><tr><td rowspan=3 colspan=1>EasyGlucoT(Capillary)vs Hitachi747</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>0.9899</td><td rowspan=1 colspan=1>0.9665 to 1.0132</td><td rowspan=1 colspan=1>0.9988</td><td rowspan=1 colspan=1>0.9608 to 1.0369</td><td rowspan=1 colspan=1>0.9678</td><td rowspan=1 colspan=1>0.9338 to 1.0018</td></tr><tr><td rowspan=1 colspan=1>Y-intercept</td><td rowspan=1 colspan=1>-1.7286</td><td rowspan=1 colspan=1>-6.3085 to2.8513</td><td rowspan=1 colspan=1>-1.4878</td><td rowspan=1 colspan=1>-9.4055 to6.4299</td><td rowspan=1 colspan=1>1.2087</td><td rowspan=1 colspan=1>-7.3271 to7.6058</td></tr><tr><td rowspan=1 colspan=1>correlationcoefficient</td><td rowspan=1 colspan=2>0.9965</td><td rowspan=1 colspan=2>0.9913</td><td rowspan=1 colspan=2>0.9926</td></tr><tr><td rowspan=3 colspan=1>EasyGluco(Palm) vs.Easy GlucoM(Capillary)</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>1.0027</td><td rowspan=1 colspan=1>0.9621 to 1.0433</td><td rowspan=1 colspan=1>0.9829</td><td rowspan=1 colspan=1>0.9377 to 1.0281</td><td rowspan=1 colspan=1>0.9923</td><td rowspan=1 colspan=1>0.9502 to 1.0344</td></tr><tr><td rowspan=1 colspan=1>Y-intercept</td><td rowspan=1 colspan=1>-1.9023</td><td rowspan=1 colspan=1>-9.7312 to5.9265</td><td rowspan=1 colspan=1>3.6644</td><td rowspan=1 colspan=1>-5.6925 13.0212</td><td rowspan=1 colspan=1>1.3687</td><td rowspan=1 colspan=1>-3.2000 to20.0982</td></tr><tr><td rowspan=1 colspan=1>correlationcoefficient</td><td rowspan=1 colspan=2>0.9898</td><td rowspan=1 colspan=2>0.9874</td><td rowspan=1 colspan=2>0.9893</td></tr></table>

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>site 1</td><td rowspan=1 colspan=1>site 2</td><td rowspan=1 colspan=1>site 3</td></tr><tr><td rowspan=1 colspan=1>OneTouch(Palm) vsHithchi747</td><td rowspan=1 colspan=1>A-regionB-region</td><td rowspan=1 colspan=1>100%0%</td><td rowspan=1 colspan=1>100%0%</td><td rowspan=1 colspan=1>100%0%</td></tr><tr><td rowspan=1 colspan=1>EasyGlucoTTM(Palm) vsHithchi747</td><td rowspan=1 colspan=1>A-regionB-region</td><td rowspan=1 colspan=1>100%0%</td><td rowspan=1 colspan=1>100%0%</td><td rowspan=1 colspan=1>100%0%</td></tr><tr><td rowspan=1 colspan=1>EasyGlucoTM(Capillary)VSHithchi747</td><td rowspan=1 colspan=1>A-regionB-region</td><td rowspan=1 colspan=1>100%0%</td><td rowspan=1 colspan=1>100%0%</td><td rowspan=1 colspan=1>100%0%</td></tr><tr><td rowspan=1 colspan=1>EasyGlucoTM(Palm) vsEasyGlucoT(Capillary)</td><td rowspan=1 colspan=1>A-regionB-region</td><td rowspan=1 colspan=1>100%0%</td><td rowspan=1 colspan=1>99%1 %</td><td rowspan=1 colspan=1>99 %1 %</td></tr></table>

Summary of test results with finger capillary blood and Arm blood.

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>site 1</td><td rowspan=1 colspan=1>95% confidenceintervals</td><td rowspan=1 colspan=1>site 2</td><td rowspan=1 colspan=1>95% confidenceintervals</td><td rowspan=1 colspan=1>site 3</td><td rowspan=1 colspan=1>95% confidenceintervals</td></tr><tr><td rowspan=3 colspan=1>One Touch(arm) vsHitachi 747</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>1.0289</td><td rowspan=1 colspan=1>0.9844 to 1.0734</td><td rowspan=1 colspan=1>1.0289</td><td rowspan=1 colspan=1>0.9844 to 1.0734</td><td rowspan=1 colspan=1>1.0114</td><td rowspan=1 colspan=1>0.9681 to 1.0547</td></tr><tr><td rowspan=1 colspan=1>Y-intercept</td><td rowspan=1 colspan=1>-2.6678</td><td rowspan=1 colspan=1>-12.6040 to7.2684</td><td rowspan=1 colspan=1>-2.6678</td><td rowspan=1 colspan=1>-12.604 to7.2684</td><td rowspan=1 colspan=1>-0.7990</td><td rowspan=1 colspan=1>-10.1027 to8.5046</td></tr><tr><td rowspan=1 colspan=1>correlationcoefficient</td><td rowspan=1 colspan=2>0.9886</td><td rowspan=1 colspan=2>0.9910</td><td rowspan=1 colspan=2>0.9888</td></tr><tr><td rowspan=3 colspan=1>EasyGlucoTM(Arm) vsHithchi747</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>1.0005</td><td rowspan=1 colspan=1>0.9684 to 1.0325</td><td rowspan=1 colspan=1>1.0005</td><td rowspan=1 colspan=1>0.9685 to 1.0325</td><td rowspan=1 colspan=1>0.9997</td><td rowspan=1 colspan=1>0.9704 to 1.0291</td></tr><tr><td rowspan=1 colspan=1>Y-intercept</td><td rowspan=1 colspan=1>-5.2097</td><td rowspan=1 colspan=1>-12.9422 to1.5275</td><td rowspan=1 colspan=1>-5.2097</td><td rowspan=1 colspan=1>-12.3667 to1.9474</td><td rowspan=1 colspan=1>-0.5469</td><td rowspan=1 colspan=1>-6.8605 to5.7668</td></tr><tr><td rowspan=1 colspan=1>correlationcoefficient</td><td rowspan=1 colspan=2>0.9937</td><td rowspan=1 colspan=2>0.9916</td><td rowspan=1 colspan=2>0.9947</td></tr><tr><td rowspan=3 colspan=1>EasyGluco(Capillary)vs Hitachi747</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>0.9857</td><td rowspan=1 colspan=1>0.9570 to 1.0144</td><td rowspan=1 colspan=1>0.9857</td><td rowspan=1 colspan=1>0.9570 to 1.0144</td><td rowspan=1 colspan=1>0.9513</td><td rowspan=1 colspan=1>0.9261 to 0.9764</td></tr><tr><td rowspan=1 colspan=1>Y-intercept</td><td rowspan=1 colspan=1>-1.654</td><td rowspan=1 colspan=1>-8.0630 to4.7550</td><td rowspan=1 colspan=1>-1.654</td><td rowspan=1 colspan=1>-12.5883 to4.0284</td><td rowspan=1 colspan=1>4.7927</td><td rowspan=1 colspan=1>-0.6164 to10.2017</td></tr><tr><td rowspan=1 colspan=1>correlationcoefficient</td><td rowspan=1 colspan=2>0.9948</td><td rowspan=1 colspan=2>0.9888</td><td rowspan=1 colspan=2>0.9957</td></tr><tr><td rowspan=3 colspan=1>EasyGluco ™(arm) vsEasyGlucoM(Capillary)</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>1.0049</td><td rowspan=1 colspan=1>0.9623 to 1.0476</td><td rowspan=1 colspan=1>1.0049</td><td rowspan=1 colspan=1>0.9623 to 1.0480</td><td rowspan=1 colspan=1>1.0411</td><td rowspan=1 colspan=1>0.9881 to 1.0840</td></tr><tr><td rowspan=1 colspan=1>Y-intercept</td><td rowspan=1 colspan=1>-1.6301</td><td rowspan=1 colspan=1>-10.9663 to7.7060</td><td rowspan=1 colspan=1>-1.6301</td><td rowspan=1 colspan=1>-10.9663 to7.7060</td><td rowspan=1 colspan=1>-3.7530</td><td rowspan=1 colspan=1>-12.7306 to5.2246</td></tr><tr><td rowspan=1 colspan=1>correlationcoefficient</td><td rowspan=1 colspan=2>0.9890</td><td rowspan=1 colspan=2>0.9872</td><td rowspan=1 colspan=2>0.9896</td></tr></table>

<table><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">site 1</td><td colspan="1" rowspan="1">site 2</td><td colspan="1" rowspan="1">sie 3</td></tr><tr><td colspan="1" rowspan="1">OneTouch(Arm) vsHithchi747</td><td colspan="1" rowspan="1">A-regionB-region</td><td colspan="1" rowspan="1">99 %1 %</td><td colspan="1" rowspan="1">99 %1 %</td><td colspan="1" rowspan="1">100%0%</td></tr><tr><td colspan="1" rowspan="1">EasyGlucoT(Arm) vsHithchi747</td><td colspan="1" rowspan="1">A-regionB-region</td><td colspan="1" rowspan="1">100%0%</td><td colspan="1" rowspan="1">100%0%</td><td colspan="1" rowspan="1">99%1%</td></tr><tr><td>EasyGluco (Capillary) VS Hithchi747</td><td>A-region B-region</td><td>100% 0%</td><td>99% 1%</td><td>100% 0%</td></tr><tr><td>EasyGluco (arm) vs</td><td></td><td></td><td></td><td></td></tr><tr><td>EasyGlucoTM (Capillary)</td><td>A-region B-region</td><td>100% 0%</td><td>99% 1%</td><td>100 % 0 %</td></tr></table>

Summary of test results with finger capillary blood and calf, thigh blood.

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>site 1</td><td rowspan=1 colspan=1>95% confidenceintervals</td><td rowspan=1 colspan=1>site 2</td><td rowspan=1 colspan=1>95% confidenceintervals</td><td rowspan=1 colspan=1>site 3</td><td rowspan=1 colspan=1>95% confidenceintervals</td></tr><tr><td rowspan=3 colspan=1>OneTouch(calf andthih) vsHithchi747</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>0.9946</td><td rowspan=1 colspan=1>0.9602 to 1.0290</td><td rowspan=1 colspan=1>0.9932</td><td rowspan=1 colspan=1>0.9621 to 1.0202</td><td rowspan=1 colspan=1>0.9962</td><td rowspan=1 colspan=1>0.9555 to 1.0370</td></tr><tr><td rowspan=1 colspan=1>Y-intercept</td><td rowspan=1 colspan=1>-2.063</td><td rowspan=1 colspan=1>-7.1885 to6.7759</td><td rowspan=1 colspan=1>1.0257</td><td rowspan=1 colspan=1>-4.134 to 6.1854</td><td rowspan=1 colspan=1>-1.0028</td><td rowspan=1 colspan=1>-9.7787 to7.1956</td></tr><tr><td rowspan=1 colspan=1>correlationcoefficient</td><td rowspan=1 colspan=2>0.9925</td><td rowspan=1 colspan=2>0.9956</td><td rowspan=1 colspan=2>0.9896</td></tr><tr><td rowspan=3 colspan=1>EasyGluco™Mcalf andthigh) vsHithchi747</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>0.9860</td><td rowspan=1 colspan=1>0.9535 to 1.0186</td><td rowspan=1 colspan=1>0.9794</td><td rowspan=1 colspan=1>0.9534 to 1.0053</td><td rowspan=1 colspan=1>0.9584</td><td rowspan=1 colspan=1>0.9304 to 0.9865</td></tr><tr><td rowspan=1 colspan=1>Y-intercept</td><td rowspan=1 colspan=1>1.5489</td><td rowspan=1 colspan=1>-5.0593 to8.1572</td><td rowspan=1 colspan=1>1.8367</td><td rowspan=1 colspan=1>-2.9695 to7.7908</td><td rowspan=1 colspan=1>4.5479</td><td rowspan=1 colspan=1>-1.2942 to10.3900</td></tr><tr><td rowspan=1 colspan=1>correlationcoefficient</td><td rowspan=1 colspan=2>0.9932</td><td rowspan=1 colspan=2>0.9956</td><td rowspan=1 colspan=2>0.9946</td></tr><tr><td rowspan=3 colspan=1>EasyGluco(Capillary)VSHithchi747</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>1.0158</td><td rowspan=1 colspan=1>0.9885 to 1.0431</td><td rowspan=1 colspan=1>0.9767</td><td rowspan=1 colspan=1>0.9492 to 1.0041</td><td rowspan=1 colspan=1>0.99927</td><td rowspan=1 colspan=1>0.9616 to 1.0238</td></tr><tr><td rowspan=1 colspan=1>Y-intercept</td><td rowspan=1 colspan=1>-4.0603</td><td rowspan=1 colspan=1>-9.5960 to1.4754</td><td rowspan=1 colspan=1>0.2492</td><td rowspan=1 colspan=1>-5.6556 to5.6541</td><td rowspan=1 colspan=1>0.8385</td><td rowspan=1 colspan=1>-5.6464 to7.3233</td></tr><tr><td rowspan=1 colspan=1>correlationcoefficient</td><td rowspan=1 colspan=2>0.9955</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>0.9950</td><td rowspan=1 colspan=2>0.9938</td></tr><tr><td rowspan=2 colspan=1>EasyGlucoT(calf andthigh) vs</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>0.9625</td><td rowspan=1 colspan=1>0.9224 to 1.0025</td><td rowspan=1 colspan=1>0.9947</td><td rowspan=1 colspan=1>0.9603 to 1.0291</td><td rowspan=1 colspan=1>0.9526</td><td rowspan=1 colspan=1>0.9098 to 0.9954</td></tr><tr><td rowspan=1 colspan=1>Y-intercept</td><td rowspan=1 colspan=1>6.9714</td><td rowspan=1 colspan=1>-1.1366 to15.0795</td><td rowspan=1 colspan=1>2.9687</td><td rowspan=1 colspan=1>-3.6572 to9.5945</td><td rowspan=1 colspan=1>8.8938</td><td rowspan=1 colspan=1>-2.7562 to15.0230</td></tr><tr><td rowspan=1 colspan=1>EasGlucoM(Capillary)</td><td rowspan=1 colspan=1>correlationcoefficient</td><td rowspan=1 colspan=2>0.9892</td><td rowspan=1 colspan=2>0.9925</td><td rowspan=1 colspan=2>0.9875</td></tr></table>

<table><tr><td></td><td></td><td>site 1</td><td>site 2</td><td>site 3</td></tr><tr><td>OneTouch (calf and thigh) vs Hithchi747</td><td>A-region B-region</td><td>100% 0%</td><td>99 % 1 %</td><td>100% 0%</td></tr><tr><td>EasyGluco (calf and thigh) vs Hithchi747</td><td>A-region B-region</td><td>100% 0%</td><td>100% 0%</td><td>100% 0%</td></tr><tr><td>EasyGlucoTM (Capillary) vs Hithchi747 EasyGlucoT</td><td>A-region B-region</td><td>100% 0%</td><td>100% 0%</td><td>100% 0%</td></tr><tr><td>(calf and thigh) vs EasyGlucoTM (Capillary)</td><td>A-region B-region</td><td>100% 0%</td><td>100% 0%</td><td>100% 0%</td></tr></table>

# Test results with finger capillary blood and palm blood

The EasyGluco $\textsuperscript { \textregistered }$ meter and EasyGluco $\textsuperscript { \textregistered }$ reagent strips blood glucose meter system was tested on 216 finger capillary blood samples (combining the data obtained from the 160 patients above and additional samples below $7 5 \mathrm { m g / d L }$ ) where the results were compared to the Hitachi laboratory method. The tables below show how the two methods compared:

The tables show differences in glucose values between the “EasyGluco $\textcircled{ R } ^ { \dag }$ and the Hitachi.” The first table represents samples for glucose results lower than $7 5 \mathrm { m g / d L }$ . The second table represents samples for glucose results greater than $7 5 \mathrm { m g / d L }$ .

<table><tr><td rowspan=1 colspan=1>Difference range in values between theHitachi value and the EasyGluco ® value</td><td rowspan=1 colspan=1>Within 5mg/dL</td><td rowspan=1 colspan=1>Within 10mg/dL</td><td rowspan=1 colspan=1>Within 15mg/dL *</td><td rowspan=1 colspan=1>Within 20mg/dL</td></tr><tr><td rowspan=1 colspan=1>The percent (and number) of samples forwhich the difference between theEasyGluco® and Hitachi value were withinthe difference range shown in the top row.</td><td rowspan=1 colspan=1>71%(29/41)</td><td rowspan=1 colspan=1>95%(39/41)</td><td rowspan=1 colspan=1>100%(41/41)</td><td rowspan=1 colspan=1>100%(41/41)</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Difference range in values between theHitachi value and the EasyGluco  value</td><td rowspan=1 colspan=1>Within5 %</td><td rowspan=1 colspan=1>Within10%</td><td rowspan=1 colspan=1>Within15%</td><td rowspan=1 colspan=1>Within20%*</td></tr><tr><td rowspan=1 colspan=1>The percent (and number) of samples forwhich the difference between theEasyGluco® and Hitachi value were withinthe difference range shown in the top row.</td><td rowspan=1 colspan=1>71%(125/175)</td><td rowspan=1 colspan=1>97%(170/175)</td><td rowspan=1 colspan=1>100%(175/175)</td><td rowspan=1 colspan=1>100%(175/175)</td></tr></table>

The EasyGluco $\textsuperscript { \textregistered }$ meter and EasyGluco $\textsuperscript { \textregistered }$ reagent strips blood glucose meter system was tested on 220 palm blood samples (combining the data obtained from the 160 patients above and additional samples below $7 5 \mathrm { m g / d L } )$ ) where the results were compared to the finger capillary blood sample. The tables below show how the two sites compare:

The tables show differences in glucose values between the “EasyGluco (Palm)” and the EasyGluco (Capillary).” The first table represents samples for glucose results lower than 75 $\mathrm { m g / d L }$ . The second table represents samples for glucose results greater than $7 5 \mathrm { m g / d L }$ .

<table><tr><td colspan="1" rowspan="1">Difference range in values between thefinger capillary value and the palm value</td><td colspan="1" rowspan="1">Within 5mg/dL</td><td colspan="1" rowspan="1">Within 10mg/dL</td><td colspan="1" rowspan="1">Within 15mg/dL *</td><td colspan="1" rowspan="1">Within 20mg/dL</td></tr><tr><td colspan="1" rowspan="1">The percent (and number) of samples forwhich the difference between the palm andcapillary value were within the differencerange shown in the top row.</td><td colspan="1" rowspan="1">80%(36/45)</td><td colspan="1" rowspan="1">96%(43/45)</td><td colspan="1" rowspan="1">100%(45/45)</td><td colspan="1" rowspan="1">100%(45/45)</td></tr><tr><td colspan="1" rowspan="1">Difference range in values between thefinger capillary value and the palm value</td><td colspan="1" rowspan="1">Within5 %</td><td colspan="1" rowspan="1">Within10%</td><td colspan="1" rowspan="1">Within15%</td><td colspan="1" rowspan="1">Within20%*</td></tr><tr><td colspan="1" rowspan="1">The percent (and number) of samples forwhich the difference between the palm andcapillary value were within the differencerange shown in the top row.</td><td colspan="1" rowspan="1">55%(96/175)</td><td colspan="1" rowspan="1">85%(149/175)</td><td colspan="1" rowspan="1">94%(165/175)</td><td colspan="1" rowspan="1">99%(174/175)</td></tr></table>

# Test results with finger capillary blood and forearm and upper arm blood

The EasyGluco $\textsuperscript { \textregistered }$ meter and EasyGluco $\textsuperscript { \textregistered }$ reagent strips blood glucose meter system was tested on 217 capillary blood samples (combining the data obtained from the 160 patients above and additional samples below $7 5 \mathrm { m g / d L }$ ) where the results were compared to the Hitachi laboratory method. The tables below show how the two methods compared:

The tables show differences in glucose values between the “EasyGluco $\textcircled{ R } ^ { \dag }$ and the Hitachi.” The first table represents samples for glucose results lower than $7 5 \mathrm { m g / d L }$ . The second table represents samples for glucose results greater than $7 5 \mathrm { m g / d L }$ .

<table><tr><td>Difference range in values between the Hitachi value and the EasyGluco ® value</td><td>Within 5 %</td><td>Within 10%</td><td>Within 15%*</td><td>Within 20%</td></tr><tr><td>The percent (and number) of samples for which the difference between the EasyGluco® and Hitachi value were within the difference range shown in the top row.</td><td>68% (24/41)</td><td>93% (38/41)</td><td>100% (41/41)</td><td>100% (41/41)</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Difference range in values between theHitachi value and the EasyGluco ® value</td><td rowspan=1 colspan=1>Within5 %</td><td rowspan=1 colspan=1>Within10%</td><td rowspan=1 colspan=1>Within15%</td><td rowspan=1 colspan=1>Within20%*</td></tr><tr><td rowspan=1 colspan=1>The percent (and number) of samples forwhich the difference between theEasyGluco® and Hitachi value were withinthe difference range shown in the top row.</td><td rowspan=1 colspan=1>57%(101/176)</td><td rowspan=1 colspan=1>86%(152/176)</td><td rowspan=1 colspan=1>99%(174/176)</td><td rowspan=1 colspan=1>99%(174/176)</td></tr></table>

The EasyGluco $\textsuperscript { \textregistered }$ meter and EasyGluco $\textsuperscript { \textregistered }$ reagent strips blood glucose meter system was tested on 217 forearm $\&$ upper arm blood samples (combining the data obtained from the 160 patients above and additional samples below $7 5 \mathrm { m g / d L }$ ) where the results were compared to the Hitachi laboratory method. The tables below show how well the two methods compared:

The tables show differences in glucose values between the “EasyGluco $\textcircled{ R } ^ { \dag }$ and the Hitachi.” The first table represents samples for glucose results lower than $7 5 \mathrm { m g / d L }$ . The second table represents samples for glucose results greater than $7 5 \mathrm { m g / d L }$ .

<table><tr><td>Difference range in values between the Hitachi value and the EasyGluco ® value</td><td>Within 5 mg/dL</td><td>Within 10 mg/dL</td><td>Within 15 mg/dL *</td><td>Within 20 mg/dL</td></tr><tr><td>The percent (and number) of samples for which the difference between the EasyGluco® and Hitachi value were within the difference range shown in the top row.</td><td>66% (27/41)</td><td>95% (39/41)</td><td>100% (41/41)</td><td>100% (41/41)</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Difference range in values between theHitachi value and the EasyGluco ® value</td><td rowspan=1 colspan=1>Within5 %</td><td rowspan=1 colspan=1>Within10%</td><td rowspan=1 colspan=1>Within15%</td><td rowspan=1 colspan=1>Within20%*</td></tr><tr><td rowspan=1 colspan=1>The percent (and number) of samples forwhich the difference between theEasyGluco® and Hitachi value were withinthe difference range shown in the top row.</td><td rowspan=1 colspan=1>61%(107/176)</td><td rowspan=1 colspan=1>91%(160/176)</td><td rowspan=1 colspan=1>97%(171/176)</td><td rowspan=1 colspan=1>99%(175/176)</td></tr></table>

The EasyGluco $\textsuperscript { \textregistered }$ meter and EasyGluco $\textsuperscript { \textregistered }$ reagent strips blood glucose meter system was tested on 218 forearm & upper arm blood samples, (combining the data obtained from the 160 patients above and additional samples below $7 5 \mathrm { m g / d L }$ ). The results were compared to the fingertip capillary blood sample. The tables below show how well the two sites compare:

The tables show differences in glucose values between the “EasyGluco (Forearm & Upper Arm)” and the EasyGluco (Capillary).” The first table represents samples for glucose results lower than $7 5 \mathrm { m g / d L }$ . The second table represents samples for glucose results greater than $7 5 \mathrm { m g / d L }$ .

<table><tr><td colspan="1" rowspan="1">Difference range in values between theCapillary value and the Forearm &amp; upper armvalue</td><td colspan="1" rowspan="1">Within 5mg/dL</td><td colspan="1" rowspan="1">Within 10mg/dL</td><td colspan="1" rowspan="1">Within 15mg/dL *</td><td colspan="1" rowspan="1">Within 20mg/dL</td></tr><tr><td colspan="1" rowspan="1">The percent (and number) of samples forwhich the difference between the Forearm &amp;upper arm and Capillary value were withinthe difference range shown in the top row.</td><td colspan="1" rowspan="1">67%(28/42)</td><td colspan="1" rowspan="1">90%(38/42)</td><td colspan="1" rowspan="1">98%(41/42)</td><td colspan="1" rowspan="1">100%(42/42)</td></tr><tr><td colspan="1" rowspan="1">Difference range in values between theCapillary value and the Forearm &amp; upperarm value</td><td colspan="1" rowspan="1">Within5 %</td><td colspan="1" rowspan="1">Within10%</td><td colspan="1" rowspan="1">Within15%</td><td colspan="1" rowspan="1">Within20%*</td></tr><tr><td colspan="1" rowspan="1">The percent (and number) of samples forwhich the difference between the Forearm&amp; upper arm and Capillary value werewithin the difference range shown in thetop row.</td><td colspan="1" rowspan="1">49%(87/176)</td><td colspan="1" rowspan="1">77%(136/176)</td><td colspan="1" rowspan="1">85%(150/176)</td><td colspan="1" rowspan="1">95%(167/176)</td></tr></table>

# Test results with finger capillary blood and calf & thigh blood

The EasyGluco $\textsuperscript { \textregistered }$ meter and EasyGluco $\textsuperscript { \textregistered }$ reagent strips blood glucose meter system was tested on 219 capillary blood samples (combining the data obtained from the 160 patients above and additional samples below $7 5 \mathrm { m g / d L } )$ ) where the results were compared to the Hitachi laboratory method. The tables below show how the two methods compared:

The tables show differences in glucose values between the “EasyGluco $\textcircled{ R } ^ { \dag }$ and the Hitachi.” The first table represents samples for glucose results lower than $7 5 \mathrm { m g / d L }$ . The second table represents samples for glucose results greater than $7 5 \mathrm { m g / d L }$ .

<table><tr><td rowspan=1 colspan=1>Difference range in values between theHitachi value and the EasyGluco  value</td><td rowspan=1 colspan=1>Within 5mg/dL</td><td rowspan=1 colspan=1>Within 10mg/dL</td><td rowspan=1 colspan=1>Within 15mg/dL *</td><td rowspan=1 colspan=1>Within 20mg/dL</td></tr><tr><td rowspan=1 colspan=1>The percent (and number) of samples forwhich the difference between theEasyGluco® and Hitachi value were withinthe difference range shown in the top row.</td><td rowspan=1 colspan=1>68%(27/40)</td><td rowspan=1 colspan=1>93%(37/40)</td><td rowspan=1 colspan=1>100%(40/40)</td><td rowspan=1 colspan=1>100%(40/40)</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Difference range in values between theHitachi value and the EasyGluco ® value</td><td rowspan=1 colspan=1>Within5 %</td><td rowspan=1 colspan=1>Within10%</td><td rowspan=1 colspan=1>Within15%</td><td rowspan=1 colspan=1>Within20%*</td></tr><tr><td rowspan=1 colspan=1>The percent (and number) of samples forwhich the difference between theEasyGluco® and Hitachi value were withinthe difference range shown in the top row.</td><td rowspan=1 colspan=1>72%(128/179)</td><td rowspan=1 colspan=1>96%(172/179)</td><td rowspan=1 colspan=1>100%(179/179)</td><td rowspan=1 colspan=1>100%(179/179)</td></tr></table>

The EasyGluco $\textsuperscript { \textregistered }$ meter and EasyGluco $\textsuperscript { \textregistered }$ reagent strips blood glucose meter system was tested on 219 calf & thigh blood samples (combining the data obtained from the 160 patients above and additional samples below $7 5 \mathrm { m g / d L }$ ) where the results were compared to the Hitachi laboratory method. The tables below show how well the two methods compared:

The tables show differences in glucose values between the “EasyGluco $\textcircled{ R } ^ { \dag }$ and the Hitachi.” The first table represents samples for glucose results lower than $7 5 \mathrm { m g / d L }$ . The second table represents samples for glucose results greater than $7 5 \mathrm { m g / d L }$ .

<table><tr><td>Difference range in values between the Hitachi value and the EasyGluco ® value</td><td>Within 5 mg/dL</td><td>Within 10 mg/dL</td><td>Within 15 mg/dL *</td><td>Within 20 mg/dL</td></tr><tr><td>The percent (and number) of samples for which the difference between the EasyGluco® and Hitachi value were within the difference range shown in the top row.</td><td>55% (22/40)</td><td>95% (38/40)</td><td>100% (40/40)</td><td>100% (40/40)</td></tr></table>

<table><tr><td>Difference range in values between the Hitachi value and the EasyGluco ® value</td><td>Within 5 %</td><td>Within 10%</td><td>Within 15%</td><td>Within 20%*</td></tr><tr><td>The percent (and number) of samples for which the difference between the EasyGluco® and Hitachi value were within the difference range shown in the top row.</td><td>73% (131/179)</td><td>97% (173/179)</td><td>100% (179/179)</td><td>100% (179/179)</td></tr></table>

The EasyGluco $\textsuperscript { \textregistered }$ meter and EasyGluco $\textsuperscript { \textregistered }$ reagent strips blood glucose meter system was tested on 219 calf & thigh blood samples (combining the data obtained from the 160 patients above and additional samples below $7 5 \mathrm { m g / d L }$ ) where the results were compared to the capillary blood sample. The tables below show how the two sites compared:

The tables show differences in glucose values between the “EasyGluco (Calf & thigh)” and the EasyGluco (Capillary).” The first table represents samples for glucose results lower than $7 5 \mathrm { m g / d L }$ . The second table represents samples for glucose results greater than $7 5 \mathrm { m g / d L }$ .

<table><tr><td colspan="1" rowspan="1">Difference range in values between theCapillary value and the Calf &amp; thigh value</td><td colspan="1" rowspan="1">Within 5mg/dL</td><td colspan="1" rowspan="1">Within 10mg/dL</td><td colspan="1" rowspan="1">Within 15mg/dL *</td><td colspan="1" rowspan="1">Within 20mg/dL</td></tr><tr><td colspan="1" rowspan="1">The percent (and number) of samples forwhich the difference between the Calf &amp;thigh and Capillary value were within thedifference range shown in the top row.</td><td colspan="1" rowspan="1">68%(27/40)</td><td colspan="1" rowspan="1">93%(37/40)</td><td colspan="1" rowspan="1">98%(39/40)</td><td colspan="1" rowspan="1">100%(40/40)</td></tr><tr><td colspan="1" rowspan="1">Difference range in values between theCapillary value and the Calf &amp; thigh value</td><td colspan="1" rowspan="1">Within5 %</td><td colspan="1" rowspan="1">Within10%</td><td colspan="1" rowspan="1">Within15%</td><td colspan="1" rowspan="1">Within20%*</td></tr><tr><td colspan="1" rowspan="1">The percent (and number) of samples forwhich the difference between the Calf &amp;thigh and Capillary value were within thedifference range shown in the top row.</td><td colspan="1" rowspan="1">56%(100/179)</td><td colspan="1" rowspan="1">89%(160/179)</td><td colspan="1" rowspan="1">99%(178/179)</td><td colspan="1" rowspan="1">100%(179/179)</td></tr></table>

b. Matrix comparison: Not applicable

3. Clinical studies:

a. Clinical Sensitivity: Not applicable.   
b. Clinical specificity: Not applicable.   
c. Other clinical supportive data (when a. and b. are not applicable):

4. Clinical cut-off: Not applicable.

5. Expected values/Reference range:

The EasyGluco Diabetes Monitoring System labeling states that self-testing of blood glucose levels provides a way to control your diabetes. Diabetics should consult with their physician to determine the best range of expected blood glucose values for them.

Expected blood glucose levels for people without diabetes:

<table><tr><td>Time</td><td>Range (mg/dL)</td><td>Range (mmol/L)</td></tr><tr><td>Before Breakfast:</td><td>70-105</td><td>3.9-5.8</td></tr><tr><td>Before lunch or dinner:</td><td>70-110</td><td>3.9-6.1</td></tr><tr><td>1 hour after meals:</td><td>Less than 160</td><td>Less than 8.9</td></tr><tr><td>2 hours after meals:</td><td>Less than 120</td><td>Less than 6.7</td></tr><tr><td>Between 2 and 4 AM:</td><td>Greater than 70</td><td>Greater than 3.9</td></tr></table>

Blood glucose levels can appear to be lower or higher after a meal, physical exercise or any other event that may affect blood glucose levels. Before taking the EASYGLUCO™ blood glucose test, wait two hours prior or after a meal, physical exercise to retrieve more accurate results.

If the test result is below $2 0 \mathrm { m g / d L }$ (1.2mmol/L), “LO” will appear on the meter display. “LO” results indicate severe hypoglycemia (low blood glucose). Consult with your physician immediately in how to treat hypoglycemia.

If the test result is above $6 0 0 \mathrm { m g / d L }$ (33.3mmol/L), “HI” will appear on the meter display. “HI” results indicate severe hyperglycemia (high blood glucose). Seek medical assistance immediately.

# IMPORTANT Notices:

If the test result is below $6 0 \mathrm { m g / d L }$ (3.3mmol/L) or over 240mg/dL (13.3mmol/L) contact your physician immediately. If the blood glucose result is unusually low or high, or you do not feel the way the result indicates, repeat the test again with a new test strip.   
• If the results are still inconsistent, contact a physician before making any decision to control your diabetes.

# These expected values are referenced from the below references.

1. National Committee for Clinical Laboratory Standards. Point-Care Blood Glucose Testing in Acute and Chroni care Facilities; Approved Guideline, $2 ^ { \mathrm { n d } }$ Edition. NCCLS Document C30-A2 (ISBN1-56238-471-6).   
2. National Committee for Clinical Laboratory Standards. Statistical Quality Control for Quantitative Measurements; Principle and Definitions; Approved Guideline, $2 ^ { \mathrm { n d } }$ Edition. NCCLS Document C24-A2 (ISBN1-56238-371-X). 1999   
3. National Committee for Clinical Laboratory Standards. Preliminary Evaluation of Quantitative Clinical Laboratory Methods; Approved Guideline. NCCLS Document EP10-A (ISBN1-56238-348-5). 1998   
4. National Committee for Clinical Laboratory Standards. Evaluation of Matrix Effects; Approved Guideline, NCCLS Document EP14-A (ISBN1-56238-434-1).   
5. National Committee for Clinical Laboratory Standards. Estimation of Total analytical Error for Clinical Laboratory Methods; Proposed Guideline. NCCLS Document EP21-P (ISBN1-56238-456-2).   
6. National Committee for Clinical Laboratory Standards. User Demonstration of performance for Precision and Accuracy; Approved Guideline. NCCLS Document EP15-A (ISBN1-56238-451-1).   
7. National Committee for Clinical Laboratory Standards. Interference Testing in Clinical Chemistry; Proposed Guideline. NCCLS Document EP7-P (ISSN 0273-3099).   
8. National Committee for Clinical Laboratory Standards. Evaluation of the Linearity of Quantitative Analytical Methods; Proposed Guideline, $2 ^ { \mathrm { n d } }$ Edition. NCCLS Document EP6-P2 (ISBN1-56238-446-5).   
9. National Committee for Clinical Laboratory Standards. Evaluation of Performance of Clinical Chemistry Devices; Approved Guideline. NCCLS Document EP5-A (ISBN1-56238-368-X).   
10. Clinical Chemistry, $2 ^ { \mathrm { n d } }$ Edition   
11. MERCK INDEX, $1 1 ^ { \mathrm { t h } }$ Edition.   
12. Korea Pharmacopeia, $5 ^ { \mathrm { t h } }$ Edition.

# N. Instrument Name:

US Diagnostics Inc. EasyGluco Diabetes Monitoring System

# O. System Descriptions:

1. Modes of Operation:

The EasyGluco Diabetes Monitoring System used with the EasyGluco Reagent Strips and EasyGluco Control Solution is a single use test system used to quantitatively measure blood glucose levels, also known as blood sugar, from fresh capillary whole blood samples taken from the fingertips, arm, palm, and thigh. The EasyGluco Diabetes Monitoring System is for in vitro diagnostic use only. The EasyGluco Diabetes Monitoring System is not intended for use with neonates.

2. Software:

FDA has reviewed applicant’s Hazard Analysis and software development processes for   
this line of product types:   
Yes __X_ or No

3. Specimen Identification:

The EasyGluco Blood Glucose Monitoring System memory will store from 7 to 90-day average and 200 tests in the memory.

4. Specimen Sampling and Handling: Refer to the EasyGluco Blood Glucose Monitoring System User’s Manual.

5. Calibration:

Code numbers are used to calibrate the EasyGluco Test Strips with the EasyGluco Meter for accurate results. The operator must confirm the code number of the meter and test strips are the same before using the meter. Once the EasyGluco test strip is inserted in the EasyGluco meter, the meter will turn on and the code number will be displayed for 3 seconds. The operator will then compare the code number on the meter LCD to the code number on the test strip vial.

If the codes do not match the operator must change the meter code to match the test strip vial code. The test strips are tested at the manufacturer at the time they are released. Based on performance characteristics for each lot of strips they are assigned code numbers. These code numbers represent the slope and intercept characteristics for each of the lots. The code number is embedded in reagent test strip.

# 6. Quality Control:

There are three EasyGluco Controls Solutions available: low, normal, and high that correspond to whole blood glucose concentrations of approximately $5 0 \pm 1 5 \mathrm { m g / d L }$ , $1 0 0 \pm$ $1 6 . 5 \mathrm { m g / d L }$ , and $3 0 0 \pm 4 5 ~ \mathrm { m g / d L }$ respectively. A control test, using an EasyGluco Control, can be used to check the meter and test strips performance. The meter test strips and testing technique are acceptable if the control test result falls within a specific control range. Users are instructed to follow the illustrated directions in the EasyGluco User Guide. Quality control testing should be performed as required by the user’s institution’s quality control policy or local regulatory requirements.

# P. Other Supportive Instrument Performance Characteristics Data Not Covered In the “Performance Characteristics” Section above:

# Q. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# R. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.